Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02270931 · ClinicalTrials.gov registry record
A Prospective Longitudinal Breast Cancer Study
A clinical trial of Breast Cancer, sponsored by Fujirebio Diagnostics.
- Completed
- Registry status
- 130
- Enrollment target
- 3
- Study locations
NCT02270931 is a study of Breast Cancer that has completed, run by Fujirebio Diagnostics. The registered enrollment target is 130 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (95% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT02270931, a study of Breast Cancer, has completed, sponsored by Fujirebio Diagnostics.
- COMPLETED
- Registry status
- 130 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to obtain sufficient specimens and correlating clinical data from a well-controlled prospective clinical trial collecting longitudinal specimens from subjects diagnosed with any stage of breast cancer.
Conditions Studied
Interventions
- DEVICE CA 15-3 Assay
Study Locations (3)
Florida
- Jane Skelton, MD - Boca Raton
- Broward Health Medical Center - Fort Lauderdale
North Carolina
- New Hanover Regional Medical Center - Wilmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2014-05 |
| Est. Completion | 2021-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02270931
The ClinicalTrials.gov registry entry for NCT02270931 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (95% lower). The listed sponsor is Fujirebio Diagnostics, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which CA 15-3 Assay is the first listed.
NCT02270931 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Florida, North Carolina.
Frequently Asked Questions
What is clinical trial NCT02270931 about?
NCT02270931 is a clinical study titled "A Prospective Longitudinal Breast Cancer Study". The purpose of this study is to obtain sufficient specimens and correlating clinical data from a well-controlled prospective clinical trial collecting longitudinal specimens from subjects diagnosed with any stage of breast cancer.
What is the current status of trial NCT02270931?
This trial is currently completed. The enrollment target is 130 participants. The study started on 2014-05. Estimated completion is 2021-06-30.
What conditions does trial NCT02270931 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT02270931?
The interventions under investigation include: CA 15-3 Assay (DEVICE).
Who is sponsoring clinical trial NCT02270931?
This trial is sponsored by Fujirebio Diagnostics, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02270931 being conducted?
This trial has 3 study locations across Florida, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.